# NLK facilitates Caspase‐8 activation to drive macrophage PANoptosis in sepsis

**Authors:** Yun Xia, Ren‐qi Yao, Hui‐fan Liu, Guo‐qing Jing, Delida Aidebaike, Jing Zuo, Shi‐qi Wan, Die Wu, Peng‐yue Zhao, Hai‐long Gong, Xing Wang, Hui‐min Zhou, Ning Dong, Yao Wu, Shi Liu, Xiao‐jing Wu, Yong‐ming Yao, Xue‐min Song

PMC · DOI: 10.1002/ctm2.70616 · Clinical and Translational Medicine · 2026-02-11

## TL;DR

NLK promotes Caspase-8 activation in macrophages, driving inflammatory cell death and worsening sepsis outcomes.

## Contribution

NLK is identified as a novel regulator of Caspase-8-mediated PANoptosis in sepsis.

## Key findings

- NLK deficiency reduces Caspase-8 cleavage and shifts cell death toward necroptosis.
- NLK interacts with Caspase-8 to enhance its activation in PANoptosome complexes.
- NLK deletion improves survival and reduces organ injury in sepsis models.

## Abstract

Mounting evidence indicates that macrophage PANoptosis—an integrated inflammatory cell‐death program comprising pyroptosis, apoptosis, and necroptosis—plays a pivotal role in sepsis pathogenesis. However, its upstream regulation remains poorly understood. Here, we identify Nemo‐like kinase (NLK) as a novel regulator of Caspase‐8–mediated PANoptotic signalling in sepsis. Integrated analyses of bulk (GSE65682) and single‐cell (GSE167363) transcriptomic datasets from patients with sepsis revealed elevated NLK expression in monocytes, strongly associated with PANoptotic effectors and adverse outcomes. Functional studies using NLK conditional knockout mice driven by Csf1r‐iCre and lipopolysaccharide‐stimulated bone‐marrow‐derived macrophages showed that NLK deficiency attenuated Caspase‐8 cleavage, suppressed pyroptotic (cleaved Caspase‐1, GSDMD‐N) and apoptotic (cleaved Caspase‐3/7) activation, and redirected cell‐death execution towards a necroptosis‐dominant program (p‐RIPK1/3, p‐MLKL). This death‐mode redistribution was associated with attenuated cytokine release, reduced multiorgan injury, and improved survival. Mechanistically, NLK associated with the N‐terminal death effector domains (DEDs; amino acids 1–216) of Caspase‐8, thereby enhancing the efficiency of Caspase‐8 recruitment and proximity‐induced activation within FADD–RIPK1/3‐containing PANoptosome complexes. NLK deletion impaired Caspase‐8 activation within these complexes and promoted RIPK1–RIPK3 necrosome assembly. Moreover, Caspase‐8 overexpression in NKO macrophages partially restored GSDMD and Caspase‐3 cleavage and reduced p‐MLKL, confirming that NLK is required for efficient Caspase‐8 activation and optimal PANoptotic signalling. Collectively, these findings identify NLK as a regulatory rheostat of Caspase‐8–associated PANoptosis in sepsis and highlight the NLK–Caspase‐8 axis as a potential therapeutic target for fine‐tuning sepsis‐associated inflammatory cell death.

By promoting Caspase‐8 activation within the PANoptosome, NLK modulates pyroptotic, apoptotic, and necroptotic programs in macrophages, thereby driving inflammatory injury and multiorgan damage during sepsis.

## Linked entities

- **Genes:** NLK (nemo like kinase) [NCBI Gene 51701], casp8 (caspase 8, apoptosis-related cysteine peptidase) [NCBI Gene 58022], FADD (Fas associated via death domain) [NCBI Gene 8772], RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035], GSDMD (gasdermin D) [NCBI Gene 79792], Caspase1 (caspase-1) [NCBI Gene 692604], Casp3 (caspase 3) [NCBI Gene 12367], Casp7 (caspase 7) [NCBI Gene 12369], MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259]
- **Proteins:** casp8 (caspase 8, apoptosis-related cysteine peptidase), FADD (Fas associated via death domain), RIPK1 (receptor interacting serine/threonine kinase 1), RIPK3 (receptor interacting serine/threonine kinase 3), GSDMD (gasdermin D), Caspase1 (caspase-1), Casp3 (caspase 3), Casp7 (caspase 7), MLKL (mixed lineage kinase domain like pseudokinase)

## Full-text entities

- **Genes:** GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, NLK (nemo like kinase) [NCBI Gene 51701], RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}
- **Diseases:** inflammatory (MESH:D007249), multiorgan injury (MESH:D014947), sepsis (MESH:D018805)
- **Chemicals:** lipopolysaccharide (MESH:D008070)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12894773/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12894773/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12894773/full.md

---
Source: https://tomesphere.com/paper/PMC12894773